Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-07-08 8:54 pm Purchase | 2024-06-28 | 13D | KALA BIO, INC. KALA | SR One Capital Management, LLC | 8,913 9.990% | 8,913 (New Position) | Filing History |
| 2024-06-28 4:11 pm Purchase | 2024-06-26 | 13D | KALA BIO, INC. KALA | Baker Bros. Advisors LP | 17,827 19.990% | 12,443 (+231.11%) | Filing History |
| 2024-02-16 4:11 pm Purchase | 2024-02-09 | 13G | KALA BIO, INC. KALA | Millennium Management LLC | 2,702 5.000% | 2,702 (New Position) | Filing History |
| 2024-02-14 4:21 pm Purchase | 2023-12-31 | 13G | KALA BIO, INC. KALA | Baker Bros. Advisors LP | 5,384 9.990% | 1,766 (+48.81%) | Filing History |
| 2024-02-14 1:09 pm Sale | 2023-12-31 | 13G | KALA BIO, INC. KALA | Checkpoint Capital L.P. | 0 0.000% | -4,561 (Position Closed) | Filing History |
| 2024-01-29 4:36 pm Sale | 2023-12-31 | 13G | KALA BIO, INC. KALA | Integrated Core Strategies (US) LLC | 2,653 4.900% | -21 (-0.79%) | Filing History |
| 2023-10-18 4:04 pm Unchanged | 2023-05-01 | 13D | KALA PHARMACEUTICALS INC KALA | Longitude Capital Partners II, LLC | 2,165 4.300% | 0 (Unchanged) | Filing History |
| 2023-06-15 11:57 am Purchase | 2023-06-05 | 13G | KALA BIO, INC. KALA | Checkpoint Capital L.P. | 4,561 9.700% | 4,561 (New Position) | Filing History |
| 2023-02-14 4:15 pm Sale | 2022-12-31 | 13D | KALA PHARMACEUTICALS INC KALA | Longitude Capital Partners II, LLC | 2,165 6.300% | -2,201 (-50.41%) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | KALA BIO, INC. KALA | Baker Bros. Advisors LP | 3,618 9.990% | 3,618 (New Position) | Filing History |
| 2023-01-17 4:38 pm Purchase | 2023-01-04 | 13G | KALA BIO, INC. KALA | Integrated Core Strategies (US) LLC | 2,674 8.400% | 2,674 (New Position) | Filing History |
| 2022-06-03 5:11 pm Sale | 2022-06-02 | 13D | KALA PHARMACEUTICALS INC KALA | RA Capital Management, L.P. | 2,730 4.700% | -2,226 (-44.92%) | Filing History |
| 2022-05-31 5:31 pm Sale | 2022-05-26 | 13D | KALA PHARMACEUTICALS INC KALA | RA Capital Management, L.P. | 4,956 8.530% | -1,480 (-23.00%) | Filing History |
| 2022-05-25 5:12 pm Sale | 2022-05-23 | 13D | KALA PHARMACEUTICALS INC KALA | RA Capital Management, L.P. | 6,436 11.080% | -2,296 (-26.29%) | Filing History |
| 2022-04-01 4:30 pm Sale | 2022-03-30 | 13D | KALA PHARMACEUTICALS INC KALA | RA Capital Management, L.P. | 8,732 15.030% | -37 (-0.42%) | Filing History |
| 2022-02-14 11:50 am Sale | 2021-12-31 | 13G | KALA PHARMACEUTICALS INC KALA | Eventide Asset Management, LLC | 0 0.000% | -2,760 (Position Closed) | Filing History |
| 2022-01-10 12:54 pm Sale | 2021-12-31 | 13G | KALA PHARMACEUTICALS INC KALA | BlackRock, Inc. BLK | 2,508 4.800% | -20 (-0.79%) | Filing History |
| 2021-11-26 4:17 pm Purchase | 2021-11-15 | 13D | KALA PHARMACEUTICALS INC KALA | Lagunita LLC | 4,273 7.300% | 4,273 (New Position) | Filing History |
| 2021-11-26 4:16 pm Purchase | 2021-11-15 | 13D | KALA PHARMACEUTICALS INC KALA | Lagunita Biosciences LLC | 4,273 7.300% | 4,273 (New Position) | Filing History |
| 2021-11-24 2:27 pm Purchase | 2021-11-15 | 13D | KALA PHARMACEUTICALS INC KALA | Blumenkranz Mark S. | 4,273 7.300% | 4,273 (New Position) | Filing History |